Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo

Temozolomide (TMZ) is a conventional chemotherapy drug for adjuvant treatment of glioblastoma multiforme (GBM), often accompanied by dexamethasone (DXM) to prevent brain oedema and alleviate clinical side effects. Here, we aimed to investigate an ability of the drugs to affect normal brain tissue in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Tsidulko, Alexandra Y., Bezier, Cynthia, de La Bourdonnaye, Gabin, Suhovskih, Anastasia V., Pankova, Tatiana M., Kazanskaya, Galina M., Aidagulova, Svetlana V., Grigorieva, Elvira V.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2018
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6176078/
https://ncbi.nlm.nih.gov/pubmed/30333749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01104
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk